Palliative care for people with non-malignant lung disease: Summary of current evidence and future direction

Palliative Medicine

Volumn 27, Issue 9, 2013, Pages 811-816

  Boland, Jason ^a,b   Martin, Jonathan ^c,d   Wells, Athol U ^e,f   Ross, Joy R ^e,g  

^a UNIVERSITY OF HULL   (United Kingdom)

^b Care Plus Group and St Andrews Hospice   (United Kingdom)

^c St Joseph's Hospice   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^f ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^g ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

chronic obstructive pulmonary disease; cystic fibrosis; interstitial lung disease; non malignant lung disease; Palliative care

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CYSTIC FIBROSIS; DAILY LIFE ACTIVITY; DYSPNEA; HEALTH CARE DELIVERY; HUMAN; INTERSTITIAL LUNG DISEASE; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; OXYGEN THERAPY; PAIN ASSESSMENT; PALLIATIVE THERAPY; PROGNOSIS; PSYCHOSOCIAL CARE; PULMONARY REHABILITATION; QUALITY OF LIFE; SOCIAL ISOLATION;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CYSTIC FIBROSIS; INTERSTITIAL LUNG DISEASE; NON-MALIGNANT LUNG DISEASE; PALLIATIVE CARE;

CYSTIC FIBROSIS; DELIVERY OF HEALTH CARE; DYSPNEA; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LUNG DISEASES, INTERSTITIAL; PALLIATIVE CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884511556     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216313493467     Document Type: Article

References (42)

1. Department of Health. End of life care strategy: promoting high quality care for all adults at the end of life, https://www.gov.uk/government/uploads/ system/uploads/attachment-data/file/136431/End-of-life-strategy.pdf (2008, accessed 28 October 2012).
2. Edmonds P, Karlsen S, Khan S, et al. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med. 2001 ; 15 (4). 287-295
3. Song MK, De Vito Dabbs A, Studer SM, et al. Palliative care referrals after lung transplantation in major transplant centers in the United States. Crit Care Med. 2009 ; 37 (4). 1288-1292
4. Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J. 2008 ; 32 (3). 796-803
5. Tomison G, McDowell JR. Nurses' needs in delivering palliative care for long-term conditions. Br J Community Nurs. 2011 ; 16 (6). 274 278-276 281
6. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 ; 350 (10). 1005-1012
7. Small N, Gardiner C, Barnes S, et al. Using a prediction of death in the next 12 months as a prompt for referral to palliative care acts to the detriment of patients with heart failure and chronic obstructive pulmonary disease. Palliat Med. 2010 ; 24 (7). 740-741
8. The National Gold Standards Framework Centre. Prognostic indicator guidance, http://www.goldstandardsframework.org.uk/Resources/ Gold%20Standards%20Framework/General/ Prognostic%20Indicator%20Guidance%20October%202011.pdf (2011, accessed 25 October 2012).
9. Walke LM, Byers AL, Tinetti ME, et al. Range and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failure. Arch Intern Med. 2007 ; 167 (22). 2503-2508
10. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008 ; 134: 43S - 56S
11. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006 ; 31 (1). 58-69
12. Curtis JR, Wenrich MD, Carline JD, et al. Patients' perspectives on physician skill in end-of-life care: differences between patients with COPD, cancer, and AIDS. Chest. 2002 ; 122 (1). 356-362
13. Gardiner C, Gott M, Small N, et al. Living with advanced chronic obstructive pulmonary disease: patients concerns regarding death and dying. Palliat Med. 2009 ; 23 (8). 691-697
14. Seamark DA, Blake SD, Seamark CJ, et al. Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. An interpretative phenomenological analysis. Palliat Med. 2004 ; 18 (7). 619-625
15. Bajwah S, Higginson IJ, Ross JR, et al. Specialist palliative care is more than drugs: a retrospective study of ILD patients. Lung. 2012 ; 190 (2). 215-220
16. Swigris JJ, Kuschner WG, Jacobs SS, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax. 2005 ; 60 (7). 588-594
17. Bajwah S, Koffman J, Higginson IJ, et al. 'I wish I knew more...' - the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals. BMJ Support Palliat Care. 2013 ; 3: 84-90
18. Bajwah S, Koffman J, Higginson IJ, et al. 'When it's really really bad, I'd make a trade with the devil...' - the specialist palliative care needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals. Palliat Med. :
19. Stenekes SJ, Hughes A, Gregoire MC, et al. Frequency and self-management of pain, dyspnea, and cough in cystic fibrosis. J Pain Symptom Manage. 2009 ; 38 (6). 837-848
20. Braithwaite M, Philip J, Tranberg H, et al. End of life care in CF: patients, families and staff experiences and unmet needs. J Cyst Fibros. 2011 ; 10 (4). 253-257
21. Dellon EP, Shores MD, Nelson KI, et al. Family caregiver perspectives on symptoms and treatments for patients dying from complications of cystic fibrosis. J Pain Symptom Manage. 2010 ; 40 (6). 829-837
22. Partridge MR, Khatri A, Sutton L, et al. Palliative care services for those with chronic lung disease. Chron Respir Dis. 2009 ; 6 (1). 13-17
23. London Respiratory Team. COPD 'Value' pyramid: what we know...cost/QALY, http://www.improvement.nhs.uk/lung/NationalImprovementProjects/ AccurateDiagnosis/SuspectedCOPD/Therapy.aspx (2011, accessed 5 November 2012).
24. Bausewein C, Booth S, Gysels M, et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008 ; 2 :
25. Galbraith S, Fagan P, Perkins P, et al. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage. 2010 ; 39 (5). 831-838
26. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011 ; 42 (3). 388-399
27. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002 ; 57 (11). 939-944
28. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003 ; 327 (7414). 523-528
29. BoothSMoffatCBurkinJ. Cambridge breathlessness intervention service manual. Addenbrooke's BIS Press, http://www.cuh.org.uk/breathlessness (2012).
30. Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2010 ; 1 :
31. Uronis H, McCrory DC, Samsa G, et al. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011 ; 6 :
32. Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010 ; 376 (9743). 784-793
33. Marciniuk DD, Goodridge D, Hernandez P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011 ; 18 (2). 69-78
34. Gomutbutra P, O'Riordan DL, Pantilat SZ. Management of moderate-to-severe dyspnea in hospitalized patients receiving palliative care. J Pain Symptom Manage. 2013 ; 45 (5). 885-891
35. Sinuff T, Cook DJ, Keenan SP, et al. Noninvasive ventilation for acute respiratory failure near the end of life. Crit Care Med. 2008 ; 36 (3). 789-794
36. Curtis JR, Cook DJ, Sinuff T, et al. Noninvasive positive pressure ventilation in critical and palliative care settings: understanding the goals of therapy. Crit Care Med. 2007 ; 35 (3). 932-939
37. Bajwah S, Ross JR, Peacock JL, et al. Interventions to improve symptoms and quality of life of patients with fibrotic ILD: a systematic review of the literature. Thorax. :
38. Boland J, Owen J, Ainscough R, et al. Developing a service for patients with very severe chronic obstructive pulmonary disease (COPD) within resources. BMJ Support Palliat Care. :
39. Ewing G, Farquhar M, Booth S. Delivering palliative care in an acute hospital setting: views of referrers and specialist providers. J Pain Symptom Manage. 2009 ; 38 (3). 327-340
40. Johnson MJ, Abernethy AP, Currow DC. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?. J Pain Symptom Manage. 2012 ; 43 (3). 614-624
41. Johnson MJ, Abernethy AP, Currow DC. The evidence base for oxygen for chronic refractory breathlessness: issues, gaps, and a future work plan. J Pain Symptom Manage. 2013 ; 45 (4). 763-775
42. Boland J, Johnson M. End-of-life care for non-cancer patients. BMJ Support Palliat Care. 2013 ; 3: 2-3